Vitrolife AB (LTS:0YAY)
kr 219.5 0 (0%) Market Cap: 29.50 Bil Enterprise Value: 30.63 Bil PE Ratio: 0 PB Ratio: 2.25 GF Score: 90/100

Vitrolife AB Acquires Igenomix SL- Conference Call Transcript

Jul 09, 2021 / 08:00AM GMT
Release Date Price: kr404.4 (+1.43%)
Operator

Good day, and thank you for standing by. Welcome to the Vitrolife presentation. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand over the call to your first speaker today, Mr. Thomas Axelsson. Thank you. Please go ahead.

Thomas Axelsson;publ;CEO
Vitrolife AB

()-

Thank you very much, and welcome to Vitrolife presentation today on the 9th of July. The topic today is that Vitrolife acquires Igenomix. And by that, we will create a global leader in reproductive health.

Today's speakers, if you go to Page #2, is Mikael Engblom, the CFO of the company; and myself, Thomas Axelsson, and I am the CEO of the company. If you then go to Page #3, you will see what we are trying to cover today in this short meeting. And since we don't have so much time, let's go into direct the transaction highlights on Page #4.

The reason behind this is, from our side, quite obvious. Vitrolife is, as you know, a company that are producing, selling

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot